1.
Ann Transl Med
; 7(7): 147, 2019 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31157268
RESUMO
Chronic subclinical inflammation is a central process in the pathogenesis of cardiovascular disease (CVD) and it has been linked with both the initiation and progression of atherosclerosis. Several pro-inflammatory cytokines, such as the C-reactive protein (CRP), tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) have been described as independent risk factors for coronary heart disease and promoters of atherogenesis. Thus, extensive research is being conducted to assess the role of anti-inflammatory therapy in the primary and secondary prevention of CVD. Our review aims to provide the clinical and scientific data pertaining to the effects of different anti-inflammatory agents administered in patients with CVD.
2.
Arq. bras. cardiol
; 111(2): 142-143, Aug. 2018.
Artigo
em Inglês
| LILACS
| ID: biblio-950207